I think the MD would be considering taking up the majority of shares remaining, he has 3 months to do his due diligence & await the decisions from the courts.
This looks like NEX's only viable path forward.
Not over yet but it's only becoming more costly for shareholders the longer the saga continues.
Everything depends on the courts looming decisions, I'd say the directors know this and may have held back in response to the issues facing the company.
NEX needed something for shareholders to invest in, the failed to address this before raising capital.
The SP for the raise was well over tote odds & poorly orchestrated.
- Forums
- ASX - By Stock
- Ann: Rights issue results
I think the MD would be considering taking up the majority of...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NME (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.16M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.037 |
1 | 80000 | 0.025 |
1 | 500000 | 0.015 |
1 | 999930 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 10000 | 1 |
0.045 | 24095 | 2 |
0.047 | 48379 | 2 |
0.048 | 10000 | 1 |
0.049 | 40000 | 1 |
Last trade - 16.12pm 09/10/2024 (20 minute delay) ? |
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
NME (ASX) Chart |
Day chart unavailable
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online